Definitive Healthcare Corp. (NASDAQ:DH) Shares Bought by OLD National Bancorp IN

OLD National Bancorp IN grew its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 19.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,652 shares of the company’s stock after buying an additional 4,039 shares during the quarter. OLD National Bancorp IN’s holdings in Definitive Healthcare were worth $245,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Global Retirement Partners LLC increased its position in shares of Definitive Healthcare by 86.0% in the third quarter. Global Retirement Partners LLC now owns 4,171 shares of the company’s stock worth $31,000 after acquiring an additional 1,928 shares in the last quarter. Arizona State Retirement System increased its position in shares of Definitive Healthcare by 13.6% in the fourth quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock worth $142,000 after acquiring an additional 1,701 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Definitive Healthcare in the third quarter worth approximately $116,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Definitive Healthcare by 209.8% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,209 shares of the company’s stock worth $161,000 after acquiring an additional 10,977 shares in the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC purchased a new position in shares of Definitive Healthcare in the third quarter worth approximately $131,000. 98.67% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently commented on DH. Needham & Company LLC downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th. Stifel Nicolaus lowered their price objective on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Wednesday, January 17th. Canaccord Genuity Group cut shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Barclays lifted their target price on shares of Definitive Healthcare from $10.00 to $11.00 and gave the company an “equal weight” rating in a research note on Friday, March 1st. Finally, Canaccord Genuity Group lifted their target price on shares of Definitive Healthcare from $9.00 to $10.00 and gave the company a “hold” rating in a research note on Thursday, February 29th. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $11.31.

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock opened at $6.73 on Friday. The firm has a fifty day simple moving average of $8.16 and a 200-day simple moving average of $8.29. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare Corp. has a 1-year low of $5.53 and a 1-year high of $12.45.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The firm had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. As a group, research analysts expect that Definitive Healthcare Corp. will post 0.11 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.